Bristol-Myers Squibb Company Appoints Christopher Perley As Devens General Manager

DEVENS, Mass.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced that Christopher Perley has been named vice president and general manager of its Devens biologics manufacturing facility. In this role, Perley will be responsible for continuing the supervision of the project to build the Devens facility and will have overall management responsibility for the site and facility when it becomes operational in 2011.
MORE ON THIS TOPIC